The PATCH trial: efficacy and safety of 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a study protocol for a multicentric, double-blind, enriched enrolment randomised withdrawal, vehicle-controlled study

INTRODUCTION: Trigeminal neuralgia (TN) is characterised by a sudden, severe, electric shock like paroxysmal pain, which is almost always associated with triggers. Carbamazepine is the first-line medical management of TN. However, side effects are common. Currently, there is no ideal treatment for T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chunmei, Shrestha, Niti, Liu, Hongbing, Shen, Ying, Meng, Lan, Fan, Bifa, Luo, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330571/
https://www.ncbi.nlm.nih.gov/pubmed/34341037
http://dx.doi.org/10.1136/bmjopen-2020-045493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330571/
https://www.ncbi.nlm.nih.gov/pubmed/34341037
http://dx.doi.org/10.1136/bmjopen-2020-045493

Ejemplares similares